SkySpam1 schreef:
CORRECT: GTC Biotherapeutics' quarterly loss narrows
SAN FRANCISCO (MarketWatch) -- GTC Biotherapeutics Inc. GTCB shares rose 7.4% to $1.04 in Monday morning trade after the Framingham, Mass.-based company reported a fourth-quarter net loss of $7.43 million, or 10 cents a share, compared with $8.26 million, or 15 cents a share in the year-ago period. Revenue rose to $2.82 million from $629,000. There were 73.6 million shares outstanding in the fourth-quarter of 2006, compared with 53.6 million in the comparable period last year. (Corrects headline to reflect that the company's fourth-quarter loss narrowed.)
askmerrill.ml.com/short_market_news/0,2852,39146_5882050231-891084617,00.html
COPYRIGHT 2007 CBS MarketWatch.com